Drug Topics

MAY 5, 2024

Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.

247

247

Pharmacy Times

MAY 5, 2024

With these findings contributing to the understanding of neighborhood-level asthma risks, the authors note next steps can involve identifying and addressing disparities.

147

147

Drug Topics

MAY 5, 2024

In case you missed it, this week we had news about marijuana reclassification, the Change Healthcare cyberattack, declining wages among community pharmacists, and more.

247

247

The Checkup by Singlecare

MAY 5, 2024

Compare Biktarvy alternatives | Triumeq | Dovato | Genvoya | Stribild | Cabenuva | Natural alternatives | How to switch meds Biktarvy is a brand-name prescription medication approved by the U.S. Food and Drug Administration ( FDA ) to treat human immunodeficiency virus type 1 (HIV-1) infections. Biktarvy is recommended as an initial treatment option for people starting HIV-1 therapy.

Immunization 98

Immunization People Management FDA Dosage 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

BioPharm

MAY 5, 2024

Digital transformation is allowing for better handling, analysis, and protection of vast data collection.

52

52

Med Ed 101

MAY 5, 2024

Is it safe for women to breastfeed while taking antidepressants? According to a CDC report from 2020, ~10.3% of women ages 18-39 take antidepressants, and the number of people diagnosed with depression and taking antidepressants continues to rise. In this article, we will look at the use of SSRIs in lactation. All antidepressants pass into […] The post SSRIs In Lactation appeared first on Med Ed 101.

52

52

The FDA Law Blog

MAY 5, 2024

By Larry K. Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance (Apr. 30, 2024).

Controlled Substances 95

Controlled Substances FDA Chemotherapy Dosage 95

The Checkup by Singlecare

MAY 5, 2024

Injectable drugs called GLP-1 agonists have become popular lately, thanks to their high level of success in treating Type 2 diabetes (and their sometimes jaw-dropping side effect of extreme weight loss). These drugs work by stimulating the pancreas to produce more insulin, which helps lower blood glucose levels. They also tend to decrease appetite and slow digestion.

Insurance 98

Insurance Insurance Coverage FDA 98

The Checkup by Singlecare

MAY 5, 2024

Prednisone and Benadryl are medications often used to treat symptoms of allergic reactions and inflammatory conditions. Prednisone is a corticosteroid that reduces inflammation by suppressing the immune system’s response. On the other hand, Benadryl is a brand-name drug containing diphenhydramine, an antihistamine that blocks the effects of a chemical released during an allergic reaction called histamine.

Dosage 98

Dosage Vaccines Immunization FDA 98

The Checkup by Singlecare

MAY 5, 2024

Attention deficit hyperactivity disorder (ADHD) can be effectively treated with Strattera or Vyvanse , both of which can alleviate the lack of focus, impulsivity , and restlessness of the disorder. Brand-name drugs like Strattera and Vyvanse are approved to treat ADHD , aiming to enhance academic, work, and social performance. Yet, they differ significantly in mechanism, use, side effects, and interactions.

Labelling 52

Labelling Insurance Dosage FDA 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Checkup by Singlecare

MAY 5, 2024

Attention deficit hyperactivity disorder ( ADHD ) is a behavioral condition characterized by inattentiveness, hyperactivity, and impulsiveness. It occurs most often in children, and there have been an estimated 6 million children in the United States who have received a diagnosis as of 2016. Although ADHD can’t be cured, there are many treatments available to minimize its symptoms and effect on your life.

Controlled Substances 52

Controlled Substances Labelling Insurance Dosage 52